Medroxyprogesterone Acetate Injection, Suspension
Product Images NDC 70518-4324

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Medroxyprogesterone Acetate (NDC 70518-4324). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This text provides information about a medroxyPROGESTERone Acetate Prefilled Single-Dose Syringe containing 150mg/mL of injectable suspension for intramuscular use. It advises to shake vigorously before use, discard any unused portion, and store between 20-25°C. The medication is produced by Amneal Pharma in Ahmedabad, India, and repackaged by RemedyRepack nc. Additional details such as NDC number, expiration date, LOT number, and source NDC are also included.*

FDA Label Image

Figure 1 (Medroxyprogesterone Acetate Injectable Suspension 1)

FDA Label Image

Chemical Structure (Medroxyprogesterone Acetate Injectable Suspension 2)

FDA Label Image

1 (Medroxyprogesterone Acetate Injectable Suspension 3)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.